The potential for using risk models in future lung cancer screening trials

por Field, John K, Raji, Olaide Y
Publicado 2010

Incorporating epistasis interaction of genetic susceptibility single nucleotide polymorphisms in a lung cancer risk prediction model

por MARCUS, MICHAEL W., RAJI, OLAIDE Y., DUFFY, STEPHEN W., YOUNG, ROBERT P., HOPKINS, RAEWYN J., FIELD, JOHN K.
Publicado 2016

Identification and Validation of an Anthracycline/Cyclophosphamide–Based Chemotherapy Response Assay in Breast Cancer

por Mulligan, Jude M., Hill, Laura A., Deharo, Steve, Irwin, Gareth, Boyle, David, Keating, Katherine E., Raji, Olaide Y., McDyer, Fionnuala A., O’Brien, Eamonn, Bylesjo, Max, Quinn, Jennifer E., Lindor, Noralane M., Mullan, Paul B., James, Colin R., Walker, Steven M., Kerr, Peter, James, Jacqueline, Davison, Timothy S., Proutski, Vitali, Salto-Tellez, Manuel, Johnston, Patrick G., Couch, Fergus J., Paul Harkin, D., Kennedy, Richard D.
Publicado 2014

Informed Conditioning on Clinical Covariates Increases Power in Case-Control Association Studies

por Zaitlen, Noah, Lindström, Sara, Pasaniuc, Bogdan, Cornelis, Marilyn, Genovese, Giulio, Pollack, Samuela, Barton, Anne, Bickeböller, Heike, Bowden, Donald W., Eyre, Steve, Freedman, Barry I., Friedman, David J., Field, John K., Groop, Leif, Haugen, Aage, Heinrich, Joachim, Henderson, Brian E., Hicks, Pamela J., Hocking, Lynne J., Kolonel, Laurence N., Landi, Maria Teresa, Langefeld, Carl D., Le Marchand, Loic, Meister, Michael, Morgan, Ann W., Raji, Olaide Y., Risch, Angela, Rosenberger, Albert, Scherf, David, Steer, Sophia, Walshaw, Martin, Waters, Kevin M., Wilson, Anthony G., Wordsworth, Paul, Zienolddiny, Shanbeh, Tchetgen, Eric Tchetgen, Haiman, Christopher, Hunter, David J., Plenge, Robert M., Worthington, Jane, Christiani, David C., Schaumberg, Debra A., Chasman, Daniel I., Altshuler, David, Voight, Benjamin, Kraft, Peter, Patterson, Nick, Price, Alkes L.
Publicado 2012